UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

145P Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S120-S121

2016

Link zum Volltext

Verfügbarkeit prüfen

159P Early radiological response (ERR) as predictor of overall survival in non small cell lung cancer (NSCLC) patients with EGFR mutations

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S127-S127

2016

Link zum Volltext

Verfügbarkeit prüfen

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer

Clinical & translational oncology, 2013-11, Vol.15 (11), p.897-902

2013

Link zum Volltext

Verfügbarkeit prüfen

Pain in clinical oncology: Patient satisfaction with management of cancer pain

European journal of pain, 2012-03, Vol.16 (3), p.381-389

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study

The breast journal, 2007-11, Vol.13 (6), p.571-574

2007

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients

Annals of oncology, 1997-06, Vol.8 (6), p.547-553

1997

Link zum Volltext

Verfügbarkeit prüfen

Impact of second primary tumors of head and neck region after a previous tumor in that area

Annals of oncology, 2016-10, Vol.27, p.vi349-vi349

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-01, Vol.17 (1), p.12-18

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)

Sarcoma, 2006, Vol.2006, p.26986-8

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1998-11, Vol.22 (2), p.139-148

1998

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Chemotherapy-Induced Nausea and Vomiting with Moderately Emetogenic Chemotherapy: Advice Study

Annals of oncology, 2014-09, Vol.25, p.iv526

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating endothelial cells, endothelial progenitor cells, microparticles, and markers of inflammation and coagulation in advanced non-small cell lung cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7583-7583

2011

Link zum Volltext

Verfügbarkeit prüfen

Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia

Medical oncology (Northwood, London, England), 2002-01, Vol.19 (3), p.161-166

2002

Link zum Volltext

Verfügbarkeit prüfen

Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2001-11, Vol.34 (2), p.305-311

2001

Link zum Volltext

Verfügbarkeit prüfen

Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients

European journal of cancer (1990), 1996-09, Vol.32 (10), p.1739-1743

1996

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables

Clinical & translational oncology, 2007-07, Vol.9 (7), p.452-458

2007

Link zum Volltext

Verfügbarkeit prüfen

Long-term results after combined modality treatment for non-metastatic osteosarcoma

Cancer Immunology, Immunotherapy, 1999-12, Vol.16 (4), p.255-260

1999

Link zum Volltext

Verfügbarkeit prüfen

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study: Breast Cancer Follow-Up: Cost-Benefit Analysis

The breast journal, 2007-11, Vol.13 (6), p.571-574

2007

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib for first line treatment in unselected patients (p) with advanced or metastatic non-small cell lung carcinoma (NSCLC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7639-7639

2007

Link zum Volltext

Verfügbarkeit prüfen

An epidemiological study of the perception of asthenia by oncologists in cancer patients: POA study

Clinical & translational oncology, 2008-05, Vol.10 (5), p.288-293

2008

Link zum Volltext

Verfügbarkeit prüfen

Extragonadal Germ Cell Tumors: Prognostic Factors and Long-Term Follow-Up

European urology, 1995, Vol.28 (1), p.19-24

1995

Link zum Volltext

Verfügbarkeit prüfen

Peritoneal mesothelioma: an inusual clinical presentation in a patient without exposure to asbestos

Anales de medicina interna (Madrid, Spain : 1984), 2007-02, Vol.24 (2), p.81

2007

Link zum Volltext

Verfügbarkeit prüfen

Primary Lymphoma of Bone: A Clinico-Pathological Review and Analysis of Prognostic Factors

Leukemia & lymphoma, 2004-04, Vol.45 (4), p.853-855

2004

Link zum Volltext

Verfügbarkeit prüfen

Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum‐based chemotherapy

Cancer, 2002-12, Vol.95 (11), p.2408-2413

2002

Link zum Volltext

Verfügbarkeit prüfen

Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC): 145P

Journal of thoracic oncology, 2016-04, Vol.11 (4 Suppl), p.S120-S121

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(64)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(39)
Male
(32)
Adult
(24)
Female
(24)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Middle Aged
(18)
Aged
(17)
Oncology
(17)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adolescent
(11)
Prognosis
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Retrospective Studies
(8)
Treatment Outcome
(8)
Chemotherapy
(7)
Child
(6)
Combined Modality Therapy
(6)
Follow-Up Studies
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

145P Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC)

159P Early radiological response (ERR) as predictor of overall survival in non small cell lung cancer (NSCLC) patients with EGFR mutations

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer

Pain in clinical oncology: Patient satisfaction with management of cancer pain

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study

Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients

Impact of second primary tumors of head and neck region after a previous tumor in that area

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

Incidence of Chemotherapy-Induced Nausea and Vomiting with Moderately Emetogenic Chemotherapy: Advice Study

Circulating endothelial cells, endothelial progenitor cells, microparticles, and markers of inflammation and coagulation in advanced non-small cell lung cancer

Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia

Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer

Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables

Long-term results after combined modality treatment for non-metastatic osteosarcoma

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study: Breast Cancer Follow-Up: Cost-Benefit Analysis

Erlotinib for first line treatment in unselected patients (p) with advanced or metastatic non-small cell lung carcinoma (NSCLC)

An epidemiological study of the perception of asthenia by oncologists in cancer patients: POA study

Extragonadal Germ Cell Tumors: Prognostic Factors and Long-Term Follow-Up

Peritoneal mesothelioma: an inusual clinical presentation in a patient without exposure to asbestos

Primary Lymphoma of Bone: A Clinico-Pathological Review and Analysis of Prognostic Factors

Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum‐based chemotherapy

Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC): 145P

Suchergebnisse filtern